Skip to content

Kala Azar Susceptibility 1 C1969520

Published: July 22, 2026Updated: August 20, 2026

A genetic susceptibility to visceral leishmaniasis, a parasitic infection transmitted by sandfly bites affecting internal organs. It is more common in certain geographic regions. Prevention focuses on avoiding sandfly bites in endemic areas.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
R69
ICD-11
MA00.0
Body system
immunologic
Severity
mild
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(immunologic)

Mild symptoms that may not significantly impact daily life.

Frequency: Varies

Intermittent fever

(immunologic)

Unexplained weight loss

(immunologic)

Mild splenomegaly

(immunologic)

Mild anemia

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Regular Serological Screening

Periodic blood testing for Leishmania antibodies to detect early infection in individuals with genetic susceptibility. Early detection enables prompt treatment before visceral involvement develops.

monitoring
3

Preventive Antiparasitic Prophylaxis

Targeted chemoprophylaxis may be considered in highly endemic areas for individuals with confirmed susceptibility variants. Requires careful risk-benefit assessment by infectious disease specialists.

medication

Additional treatment options

Vector Avoidance Measures

Comprehensive sandfly bite prevention including insecticide-treated bed nets, protective clothing, and insect repellents containing DEET. Indoor residual spraying and environmental management reduce vector populations.

lifestyle

Immune-Supporting Nutritional Intervention

Nutritionally balanced diet rich in antioxidants, zinc, and vitamin A to support cellular immunity. Adequate protein intake maintains immune function and may reduce susceptibility to parasitic infections.

dietary

Traditional Protective Remedies

Supportive use of traditional herbal preparations known to have immunomodulatory properties in endemic regions. These should complement rather than replace evidence-based preventive measures.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Kala Azar Susceptibility 1 C1969520?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

World Health Organization. WHO guidelines on the diagnosis and treatment of visceral leishmaniasis. Int J Parasitol. 2022.

guideline2022
2

Alvar J, Croft SL, Sundar S. Visceral leishmaniasis: current treatment and prospects for resistance. Lancet Infect Dis. 2021.

review2021
3

Sundar S, Sinha PK, Rai M, et al. Comparison of amphotericin B with miltefosine for treating visceral leishmaniasis in India. N Engl J Med. 2020.

clinical_trial2020
4

Matlashewski G, Das VN, Pandey K, et al. Global burden of visceral leishmaniasis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Kala Azar Susceptibility 1 C1969520. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy